Willow Biosciences Inc (CANSF)
0.097
+0.02
(+29.33%)
USD |
OTCM |
May 31, 16:00
Willow Biosciences Market Cap: 12.32M for May 31, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 31, 2024 | 12.32M |
| May 30, 2024 | 9.522M |
| May 29, 2024 | 7.535M |
| May 28, 2024 | 7.535M |
| May 24, 2024 | 7.535M |
| May 23, 2024 | 8.226M |
| May 22, 2024 | 8.226M |
| May 21, 2024 | 8.533M |
| May 20, 2024 | 7.288M |
| May 17, 2024 | 8.060M |
| May 16, 2024 | 8.527M |
| May 15, 2024 | 8.527M |
| May 14, 2024 | 7.967M |
| May 13, 2024 | 8.310M |
| May 10, 2024 | 8.310M |
| May 09, 2024 | 8.862M |
| May 08, 2024 | 8.862M |
| May 07, 2024 | 8.862M |
| May 06, 2024 | 8.138M |
| May 03, 2024 | 8.697M |
| May 02, 2024 | 8.697M |
| May 01, 2024 | 8.697M |
| April 30, 2024 | 8.697M |
| April 29, 2024 | 8.240M |
| April 26, 2024 | 8.087M |
| Date | Value |
|---|---|
| April 25, 2024 | 8.056M |
| April 24, 2024 | 8.183M |
| April 23, 2024 | 8.100M |
| April 22, 2024 | 8.100M |
| April 19, 2024 | 7.808M |
| April 18, 2024 | 8.194M |
| April 17, 2024 | 8.316M |
| April 16, 2024 | 8.316M |
| April 15, 2024 | 8.171M |
| April 12, 2024 | 8.418M |
| April 11, 2024 | 8.227M |
| April 10, 2024 | 8.227M |
| April 09, 2024 | 9.103M |
| April 08, 2024 | 9.586M |
| April 05, 2024 | 9.586M |
| April 04, 2024 | 9.586M |
| April 03, 2024 | 9.63M |
| April 02, 2024 | 9.63M |
| April 01, 2024 | 9.63M |
| March 28, 2024 | 9.63M |
| March 27, 2024 | 8.143M |
| March 26, 2024 | 8.143M |
| March 25, 2024 | 8.143M |
| March 22, 2024 | 8.143M |
| March 21, 2024 | 8.049M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.229M
Minimum
Jun 28 2019
171.34M
Maximum
Mar 19 2021
37.61M
Average
29.02M
Median
Jul 27 2020
Market Cap Benchmarks
| Acasti Pharma Inc | 25.65M |
| Aurinia Pharmaceuticals Inc | 775.17M |
| Edesa Biotech Inc | 14.28M |
| Lexaria Bioscience Corp | 50.25M |
| Xenon Pharmaceuticals Inc | 2.875B |
Market Cap Related Metrics
| PS Ratio | 13.83 |
| Price to Book Value | 4.755 |
| Price | 0.097 |
| Earnings Yield | -76.41% |